This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

3D Bioprinting Market

Market Insights on 3D Bioprinting covering sales outlook, demand forecast & up-to-date key trends

3D Bioprinting Market by Technology (Stereolithography, Selective Laser Sintering, Electron Beam Melting, Fused Deposition Modeling), Application (Prosthetic Devices, Tissue Engineering and Regenerative Medicine), End User & Region - Forecast to 2020 - 2030

3D Bioprinting Market - About the Report

[290 Pages Report] Increasing rate of medical device manufacturing across the world has been fuelling the demand for advanced technologies. 3D bioprinting is used to design medical devices. Leading medical device and pharmaceutical manufacturing companies are focusing on improving their product portfolio across the world. The demand in this market is expected to surge in response to the lack of organ donors in adequate number. With research and development (R&D) investment within the medical devices sector poised to rise significantly, the market will gain from increasing growth opportunities in the coming years.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for 3D bioprinting. The report tracks the global sales of 3D bioprinting in 20+ high-growth markets, along with analyzing the impact COVID-19 has on the medical device industry in general, and 3D bioprinting in particular. COVID-19 pandemic will show a negative impact on the 3D bioprinting market. Due to short term shut down of production facilities of medical device industries for first few months in 2020

Customize this Report

Let us know your requirement to get
100% FREE customization

How Historical and Future Outlook of 3D Bioprinting Market Match Up?

Growing aging population across the world is expected to drive the demand for orthopedic implants, as the risk of peripheral vascular disease, diabetes-related gangrene cases, and osteoarthritis is higher among elderly individuals.

According to the World Health Organization (WHO), the global ageing population is increasing rapidly. Between 2000 and 2050, the geriatric population is expected to account for 11% to 22% of the overall world population, growing from 605 million to 2 billion over the same period.

On an average, 82% of amputations are due to peripheral vascular diseases and diabetes. Over 65% of amputations, globally, are performed on people aged 50 years and older. The increasing ageing population is expected to boost the revenue growth of the 3D bioprinting market over the forecast period. According to FMI’s analysis, 3D bioprinting sales have grown at 10.8% CAGR between 2015 and 2019.

In past few years, 3D bioprinting technology has been increasingly preferred by surgeons and patients to precisely perform and plan reconstructive surgery. Therefore, key producers of 3D bioprinting are now increasing their product portfolio with the launch of 3D printers and devices as part of their extensive manufacturing strategy, which is expected to provide opportunities for market growth in the near future.

For instance, in February 2021, Advanced Solutions announced its newest patented cGMP and UL certified bioprinter, the BioAssemblyBot® 200. It uses a four-axis robotic arm to bioprint and automate the science workflow. Moreover, Major medical device manufacturer highly rely on 3D bioprinters to manufacture medical devices such as orthopedic implants. These developments present a positive outlook for growth. FMI expects global 3D bioprinting market to grow at 12.9%CAGR through 2030.

3D Bioprinting Market Download Report Brochure

How is 3D Bioprinting a Potential Solution for Organ Transplant?

3D bioprinting method is an alternative to overcome existing organ ongoing organ donation shortage crisis worldwide, if 3D bioprinters were capable to print out any human organ. For instance, according to the U.S. Government Information on Organ Donation and Transplantation, more than 113,000 people are on the waiting list for national organ transplant as of July 2019. Unavailability of organs for transplant cause death of 20 patients per day.

Researchers are trying to develop cardiac tissue with tissue engineering in the patch form, which is implanted directly onto scar tissue. With the help of engineered cardiac tissue, researchers try to decrease the need for organ transplants, prevent subsequent events, and improve recovery. For instance, in June 2019, Imperial College London creates thumb-size patches of heart tissue which can mimic the tissue of mature heart within 30 days and it start beat continuously after three days. These patches successfully led to improvements in heart function following a heart attack after only four weeks.

3D bioprinting can be a significant solution to the organ transplant waiting crisis so that patients can receive organ for transplant in time.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Why is 3D Bioprinting Considered the New Frontier in Regenerative Healthcare?

3D bioprinting technology has been used in regenerative medicine with the help 3D printed devices such as surgical instruments and prosthetics. Currently researchers are testing out bio-ink as a way of printing cartilage, bones, and vital organs.

Ongoing research on regenerative medicine and advancements in tissue engineering are being aimed at regeneration of damaged tissues and organs with the help of 3D bioprinting. For instance, a scientists group from Tel Aviv University developed fully vascularized heart with the help 3D bioprinting by using fat tissue cells from a donor. Scientist from Swansea University UK has developed a 3D bioprinting process by using regenerative and durable biomaterial and generate an artificial bone matrix.

The Christchurch Regenerative Medicine and Tissue Engineering (CReATE) Group, a multidisciplinary research team in New Zealand, is focusing on developing innovative bio printing techniques and biomaterials using 3D bioprinting technology in order to repair damaged tissue following trauma or a disease.

The key component of the 3D bioprinting is bioink, which is important for the development of tissue structures and functional organs. Currently, inkjet bioprinting and direct ink writing are frequently preferred for 3D bioprinting of live cells.

What is the Role of 3D Bioprinting in Advanced Dermatology?

Burns and scars particularly on exposed parts of the body can adversely affect the appearance and in turn consciousness and self-confidence of an individual. Increasing number of dermal procedures and treatments across the globe is driven due to growing consumer awareness about personal appearance and increasing personal disposable income. 

According to the U.S.-based National Institute of Aging and American Academy of Plastic Surgeons, in the U.S a remarkable share of the population, mostly between the age group between 16-33, is adapting advanced dermatology, dental services, thus creating sufficient traction for product manufacturers. Growing awareness about self-care is among the major factors driving growth of the 3D bioprinting market in developed regions such as North America and Europe, as 3D bioprinting in healthcare assists in bio printing of skin tissues.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

What Is the Impact of Intellectual Property, Ethical Considerations On 3D Bioprinting Market?

Ethical, religious, and moral questions are expected to be raised about human nature of manipulating own selection process by synthetically manufacturing human body organs with the help of 3D bioprinting.

As per experts, evolution of 3D bioprinting is associated with intellectual property theft and is expected to create major challenges in the future resulting in loss of approximately US$ 100,000 Mn per year in IP, globally. For distribution of 3D printed version of a patented product, one needs to negotiate a license with patent owner or else the distribution process would considered to be violating the patent laws.

Currently, many researchers are not only trying to print non-human cells through 3D bioprinting but are also trying to merge human cells with non-human cells, which is expected to raise ethical issues over the coming years.

What’s the Impact of 3D Bioprinting on Surgical Practice?

Medical models have revolutionized surgeries and are assisting surgeons across the globe to reduce time and complexity involved in completion of a surgical procedure. Although applications of 3D-printing in the operating room is restricted to certain procedures as of now, surgeons can design their procedure in advance to reduced time and error of surgery. Surgical procedures are becoming faster, cheaper, and less dangerous resulting in cost and time saving, which means more number of surgical procedures can be performed annually.

Surgeons can study CT scan data of a patient’s blood vessels, complex surgery, bone or other organs by converting it into a digital file with the help of 3D-printing, which can be studied and manipulated. Through printed custom tools and guides, 3D bioprinting is useful for surgeries involving drilling and cutting such as joint replacement surgeries. Over the next decade, it is most likely that custom surgical guides and medical models manufactured by 3D-printing will be a standard procedure for diverse surgical procedures such as cranial implants, joint replacement, cardiac surgeries, and spinal surgeries.

What are the limitation of 3D Bioprinting?

Only certain materials such as resins, plastics, and few of metals are used for 3D bioprinting. Consumption of other materials for 3D bioprinting increases the operational cost and is time consuming. Also, the size of the printer limits the size of the product and thus, it is quiet challenging job to manufacture parts of large industrial machines.

Apart from this, there are few more limitations such as difficulty in achieving tight manufacturing tolerances and as compared to conventional subtractive manufacturing processes, the speed of production is relatively slow. Biocompatibility of materials used for manufacturing 3D Bioprinting is also a major concern when creating implantable devices or tissues to avoid allergic reactions. Also, high costs and low availability of 3D printers in various regions is a concern for the revenue growth of the 3D bioprinting market.

3D Bioprinting Market - Country-wise Insights

How Government Initiatives is Impacting China 3D bioprinting Market?

In order to accelerate innovation in 3D bioprinting technology, government and non-profit organizations are collaborating resources and coordinating standards in order to drive rapid growth of the industry.

Chinese government is providing funding for the establishment of manufacturing facility for production of biomaterials and studying 3D printed organs and tissues. In 2015, Materialise NV. opened its first pediatric 3D medical research facility at the Children’s Medical Center, Shanghai, China, with the focus on pediatric 3D modelling and medical imaging and 3D fabrication.

Also, in July 2016, Hkable Biological 3D and the local government of Fengdu county, collaborated to build first 3D bioprinting factory for medical products. The Chinese government has invested US$ 7.5 million on this new facility and started commence operations in early 2017

What is the impact of FDA Approvals on the U.S 3D Bioprinting Market?

Manufacturing method of 3D bioprinting is different than that of conventional medical devices, thus they might require different and additional forms of testing. However, currently the Food & Drug Administration (FDA) treats 3D Bioprinting same as medical devices made conventionally.

To receive FDA approval, the new device must undergo process of attaining premarket approval or its manufacturers must ascertain that new device corresponds to one already being marketed for the identical use.  Key players in the market are getting approvals for 3D bioprinting which further help to increase revenue of the 3D bioprinting market

Geriatric Population Influencing 3D bioprinting Market in Japan

Growing aging population across the world is expected to drive the demand for orthopedic implants, as the risk of osteoarthritis, diabetes-related gangrene cases, and peripheral vascular disease is higher among elderly individuals. Increasing ageing population is expected to boost the revenue growth of the 3D bioprinting market over the forecast period.

According to United Nations Population Division, World Population Prospects 2019 data, Japan has 28.2% geriatric population. Moreover significant research on 3D bioprinting also fuel the growth of the market. For instance, in 2019 Ricoh, a leading Japanese company release human cell-infused chips by spring. Ricoh operates its proprietary 3D bioprinter in Tokyo

How Are 3D Bioprinting Startups Enabling Growth In Germany?

3D bioprinting market growth in Germany is expected to happen at an accelerated pace. As per the FMI analysis, presence of new startup Companies in Germany is more. Companies such as Mecuris, Fluicell, BigRep.  Moreover, key players such as Electro Optical Systems, EnvisionTEC, GeSiM, 3D Systems, Inc present in Germany which creates significant revenue which create surge in 3D Bioprinting production in Germany.

3D Bioprinting Market - Category-wise Insights

Which is More Preferred 3D Bioprinting Technology?

The fused deposition modeling (FDM) technology is forecast by FMI to remain dominant through the forecast period. However, the inkjet-based segment is expected to exhibit growth at a much higher pace. The technology helps in printing of complex living organs and tissues. The segment is forecast to rise at above 14% CAGR through the forecast period.

Which is the Key Application for 3D Bioprinting?

3D bioprinting application is expected to be the highest in case of manufacturing orthopedic implants. According to the World Health Organization (WHO), nearly 1.71 billion have musculoskeletal conditions around the world. With the prevalence showing no signs of slowing down, focus on 3D bioprinting for orthopedic implants is expected to surge in the coming years.

Who is the Leading 3D Bioprinting End User?

Medical device manufacturers exhibit significantly high demand for 3D bioprinting. Rising demand for implants for administering effecting treatment is one of the key factors aiding the expansion of the segment. FMI has forecast it to account for over 45% of the overall market through the forecast period.

Competitive Landscape

The global market is dominated by top manufacturers- 3D Systems, Inc, GE Healthcare, Electro Optical Systems, Stratasys Ltd, Renishaw plc. Major Manufacturers are focusing on development of intermediates by offering wide range of 3D bioprinting. Moreover, Major players in 3D bioprinting market focus on enhancing their global and regional presence through acquisition and expansion. For instance, On February 2019, In January 2021, 3D Systems announced its regenerative and bioprinting solutions expansion by actively investing in the regenerative areas, in collaboration with United Therapeutics Corporation. In February 2021, TCL Hoffmann signed an exclusive distribution agreement with ExOne as a channel partner, to sell the ExOnes’s industrial solutions and technology to Australia and New Zealand. This agreement expects to strengthen the ExOne’s network sales outreach in the key Asian markets

Some of the leading companies operating in the market are:

  • 3D Systems, Inc
  • GE Healthcare
  • ExOne (S. Kent Rockwell]
  • Electro Optical Systems
  • Renishaw plc.
  • Stratasys Ltd.
  • EnvisionTEC
  • Cyfuse Biomedical K.K.
  • Formlabs, Inc.
  • Organovo Holdings Inc,
  • Allevi Inc.
  • Advanced Solutions Life Sciences, LLC
  • Aspect Biosystems
  • CELLINK
  • GeSiM
  • Bio3D Technologies Pte. Ltd.
  • Regenovo Biotechnology Co. Ltd.
  • Optomec Inc.

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence analysis available in the report.

3D Bioprinting Market - Scope of the Report

Attribute

Details

Forecast Period

2020-2030

Historical Data Available for

2016-2020

Market Analysis

USD Million for value and Units for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa

Key Segments Covered

Technology,  Application,  End User and Region

Key Companies Profiled

  • 3D Systems, Inc
  • GE Healthcare
  • ExOne (S. Kent Rockwell]
  • Electro Optical Systems
  • Renishaw plc.
  • Stratasys Ltd.
  • EnvisionTEC
  • Cyfuse Biomedical K.K.
  • Formlabs, Inc.
  • Organovo Holdings Inc,
  • Allevi Inc.
  • Advanced Solutions Life Sciences, LLC
  • Aspect Biosystems
  • CELLINK
  • GeSiM
  • Bio3D Technologies Pte. Ltd.
  • Regenovo Biotechnology Co. Ltd.
  • Optomec Inc.

Report Coverage

Market Forecast, company share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

3D bioprinting Market by Category

Technology

  • Stereolithography (SLA)
  • Selective Laser Sintering
  • Electron Beam Melting
  • Fused Deposition Modeling (FDM)
  • Laminated Object Manufacturing (LOM
  • Inkjet Printing
  • Multi-phase Jet Solidification

Application

  • Surgical Simulation and Training Models
  • Prosthetic Devices
  • Tissue Engineering and Regenerative Medicine
  • Orthopedic Implants
  • Dental Implants
  • Medical Sensors
  • Others

End User

  • Medical Device Manufacturers
  • Pharmaceutical Companies
  • Research & Academic Institutions
  • Contract Research Organizations

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

Frequently Asked Questions

The U.S currently leads the global market for 3D bioprinting. Sales in U.S will be over 36% of total demand throughout the forecast period.

Fused Deposition Modeling (FDM) are highly sought-after in every market. The demand for Fused Deposition Modeling (FDM) technology is expected to remain high in the near future, especially due to growing usage in medical device 3D bioprinting.

There are ethical problems involved in 3D bioprinting as in many other aspects of Bioengineering. These could pose challenges to the market.

Some of the leading companies offering 3D bioprinting are GE Healthcare, 3D Systems, Inc, Electro Optical Systems, Stratasys Ltd, Renishaw plc, among others.

The World Health Organization has identified prevalence of orthopedic conditions ranges from 7.2% to 36.2% globally. The rising incidence of orthopedic around the world is fuelling the demand for 3D bioprinting for producing orthopaedic implants.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Adoption / Usage Analysis

    4.2. Strategic Promotional Strategies

    4.3. Regulatory Scenario

5. COVID-19 Crisis Analysis

    5.1. Current COVID19 Statistics and Probable Future Impact

    5.2. Current GDP Projection and Probable Impact

    5.3. Current Economic Projection as compared to 2008 Economic analysis

    5.4. COVID19 and Impact Analysis, by Country 

    5.5. 2020 Market Scenario

    5.6. Recovery Scenario – Short term, Midterm and Long Term Impact

6. Global 3D Bioprinting Market Demand Analysis 2015-2019 and Forecast, 2020-2030

    6.1. Historical Market Volume (Units) Analysis, 2015-2019

    6.2. Current and Future Market Volume (Units) Projections, 2020-2030

    6.3. Y-o-Y Growth Trend Analysis

7. Global 3D Bioprinting Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Technology Type

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

8. Global 3D Bioprinting Market Demand (in Value or Size in US$ Mn) Analysis 2015-2020 and Forecast, 2020-2030

    8.1. Historical Market Value (US$ Mn) Analysis, 2015-2020

    8.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Absolute $ Opportunity Analysis

9. Market Background

    9.1. Macro-Economic Factors

        9.1.1. Global GDP Growth Outlook

        9.1.2. Global Healthcare Outlook

        9.1.3. Income Per Capita Outlook

    9.2. Forecast Factors - Relevance & Impact

        9.2.1. Growing Usage of 3D Printing in Cosmetic Surgeries

        9.2.2. Rising Cases of Chronic Diseases

        9.2.3. Rising Funding in Medical Application for Drug Development

        9.2.4. Innovation in the 3D Bioprinting

        9.2.5. Governmental and Non-governmental Support In Medical Supplies

    9.3. Market Dynamics

        9.3.1. Drivers

        9.3.2. Restraints

        9.3.3. Opportunity Analysis

10. Global 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030, by Technology 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015–2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2020-2030

        10.3.1. Stereolithography (SLA)

        10.3.2. Selective Laser Sintering

        10.3.3. Electron Beam Melting

        10.3.4. Fused Deposition Modelling (FDM)

        10.3.5. Laminated Object Manufacturing (LOM)

        10.3.6. Inkjet Printing

        10.3.7. Multi-phase Jet Solidification

    10.4. Market Attractiveness Analysis By Technology

11. Global 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030, by Application 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Application, 2015–2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2020-2030

        11.3.1. Surgical Simulation and Training Models

        11.3.2. Prosthetic Devices

        11.3.3. Tissue Engineering and Regenerative Medicine

        11.3.4. Orthopedic Implants

        11.3.5. Dental Implants

        11.3.6. Medical Sensors

        11.3.7. Other

    11.4. Market Attractiveness Analysis By Application

12. Global 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030

        12.3.1. Medical Device Manufacturers

        12.3.2. Pharmaceutical Companies

        12.3.3. Research & Academic Institutions

        12.3.4. Contract Research Organization

    12.4. Market Attractiveness Analysis By End User

13. Global 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030, by Region

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2020

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2020-2030

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        14.3.1. By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Technology

        14.3.3. By Application

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Technology

        14.4.3. By Application

        14.4.4. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

15. Latin America 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Rest of Latin America

        15.3.2. By Technology

        15.3.3. By Application

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Technology

        15.4.3. By Application

        15.4.4. By End User

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Technology

        16.3.3. By Application

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Technology

        16.4.3. By Application

        16.4.4. By End User

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Technology

        17.3.3. By Application

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Technology

        17.4.3. By Application

        17.4.4. By End User

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020

    18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Technology

        18.3.3. By Application

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Technology

        18.4.3. By Application

        18.4.4. By End User

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Oceania 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020

    19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Technology

        19.3.3. By Application

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Technology

        19.4.3. By Application

        19.4.4. By End User

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa 3D Bioprinting Market Analysis 2015–2019 and Forecast 2020-2030

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2020

    20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2020-2030

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. Northern Africa

            20.3.1.4. South Africa

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Technology

        20.3.3. By Application

        20.3.4. By End User

    20.4. Market Attractiveness Analysis

        20.4.1. By Country

        20.4.2. By Technology

        20.4.3. By Application

        20.4.4. By End User

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Key & Emerging Countries  3D Bioprinting Market Analysis 2015–2019 and Forecast 2020–2030

    21.1. U.S. 3D Bioprinting Market Analysis

        21.1.1. By Technology

        21.1.2. By Application

        21.1.3. By End User

    21.2. Canada 3D Bioprinting Market Analysis

        21.2.1. By Technology

        21.2.2. By Application

        21.2.3. By End User

    21.3. Brazil 3D Bioprinting Market Analysis

        21.3.1. By Technology

        21.3.2. By Application

        21.3.3. By End User

    21.4. Mexico 3D Bioprinting Market Analysis

        21.4.1. By Technology

        21.4.2. By Application

        21.4.3. By End User

    21.5. U.K. 3D Bioprinting Market Analysis

        21.5.1. By Technology

        21.5.2. By Application

        21.5.3. By End User

    21.6. Germany 3D Bioprinting Market Analysis

        21.6.1. By Technology

        21.6.2. By Application

        21.6.3. By End User

    21.7. France 3D Bioprinting Market Analysis

        21.7.1. By Technology

        21.7.2. By Application

        21.7.3. By End User

    21.8. Italy 3D Bioprinting Market Analysis

        21.8.1. By Technology

        21.8.2. By Application

        21.8.3. By End User

    21.9. Spain 3D Bioprinting Market Analysis

        21.9.1. By Technology

        21.9.2. By Application

        21.9.3. By End User

    21.10. Russia 3D Bioprinting Market Analysis

        21.10.1. By  Technology 

        21.10.2. By Application

        21.10.3. By End User

    21.11. India  3D Bioprinting Market Analysis

        21.11.1. By  Technology 

        21.11.2. By Application

        21.11.3. By End User

    21.12. Indonesia  3D Bioprinting Market Analysis

        21.12.1. By  Technology 

        21.12.2. By Application

        21.12.3. By End User

    21.13. China 3D Bioprinting Market Analysis

        21.13.1. By  Technology 

        21.13.2. By Application

        21.13.3. By End User

    21.14. Japan 3D Bioprinting Market Analysis

        21.14.1. By  Technology 

        21.14.2. By Application

        21.14.3. By End User

    21.15. South Korea 3D Bioprinting Market Analysis

        21.15.1. By  Technology 

        21.15.2. By Application

        21.15.3. By End User

    21.16. Australia 3D Bioprinting Market Analysis

        21.16.1. By  Technology 

        21.16.2. By Application

        21.16.3. By End User

    21.17. New Zealand 3D Bioprinting Market Analysis

        21.17.1. By  Technology 

        21.17.2. By Application

        21.17.3. By End User

    21.18. GCC Countries 3D Bioprinting Market Analysis

        21.18.1. By  Technology 

        21.18.2. By Application

        21.18.3. By End User

    21.19. South Africa 3D Bioprinting Market Analysis

        21.19.1. By  Technology 

        21.19.2. By Application

        21.19.3. By End User

    21.20. Turkey 3D Bioprinting Market Analysis

        21.20.1. By  Technology 

        21.20.2. By Application

        21.20.3. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies (3D Bioprinting)

    22.2. Market Share Analysis of Top Players

    22.3. Market Presence Analysis

        22.3.1. By Regional footprint of Players

        22.3.2. Product foot print by Players

        22.3.3. Channel Foot Print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive 

        23.3.1. 3D Systems, Inc.

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.1.4. Sales Footprint

            23.3.1.5. Strategy Overview

                23.3.1.5.1. Marketing Strategy

                23.3.1.5.2. Product Strategy

                23.3.1.5.3. Channel Strategy

        23.3.2. GE Healthcare (Concept Laser, Arcam AB) 

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.2.4. Sales Footprint

            23.3.2.5. Strategy Overview

                23.3.2.5.1. Marketing Strategy

                23.3.2.5.2. Product Strategy

                23.3.2.5.3. Channel Strategy

        23.3.3. EOS GmbH Electro Optical Systems

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.3.4. Sales Footprint

            23.3.3.5. Strategy Overview

                23.3.3.5.1. Marketing Strategy

                23.3.3.5.2. Product Strategy

                23.3.3.5.3. Channel Strategy 

        23.3.4. Renishaw plc.

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.4.4. Sales Footprint

            23.3.4.5. Strategy Overview

                23.3.4.5.1. Marketing Strategy

                23.3.4.5.2. Product Strategy

                23.3.4.5.3. Channel Strategy

        23.3.5. ExOne (S. Kent Rockwell] 

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.5.4. Sales Footprint

            23.3.5.5. Strategy Overview

                23.3.5.5.1. Marketing Strategy

                23.3.5.5.2. Product Strategy

                23.3.5.5.3. Channel Strategy

        23.3.6. Stratasys Ltd.

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.6.4. Sales Footprint

            23.3.6.5. Strategy Overview

                23.3.6.5.1. Marketing Strategy

                23.3.6.5.2. Product Strategy

                23.3.6.5.3. Channel Strategy

        23.3.7. EnvisionTEC 

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.7.4. Sales Footprint

            23.3.7.5. Strategy Overview

                23.3.7.5.1. Marketing Strategy

                23.3.7.5.2. Product Strategy

                23.3.7.5.3. Channel Strategy

        23.3.8. Cyfuse Biomedical K.K. 

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.8.4. Sales Footprint

            23.3.8.5. Strategy Overview

                23.3.8.5.1. Marketing Strategy

                23.3.8.5.2. Product Strategy

                23.3.8.5.3. Channel Strategy

        23.3.9. Formlabs, Inc. 

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.9.4. Sales Footprint

            23.3.9.5. Strategy Overview

                23.3.9.5.1. Marketing Strategy

                23.3.9.5.2. Product Strategy

                23.3.9.5.3. Channel Strategy

        23.3.10. Organovo Holdings Inc,

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.10.4. Sales Footprint

            23.3.10.5. Strategy Overview

                23.3.10.5.1. Marketing Strategy

                23.3.10.5.2. Product Strategy

                23.3.10.5.3. Channel Strategy

        23.3.11. Allevi Inc.

            23.3.11.1. Overview

            23.3.11.2. Product Portfolio

            23.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.11.4. Sales Footprint

            23.3.11.5. Strategy Overview

                23.3.11.5.1. Marketing Strategy

                23.3.11.5.2. Product Strategy

                23.3.11.5.3. Channel Strategy

        23.3.12. Advanced Solutions Life Sciences, LLC (BioBots)

            23.3.12.1. Overview

            23.3.12.2. Product Portfolio

            23.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.12.4. Sales Footprint

            23.3.12.5. Strategy Overview

                23.3.12.5.1. Marketing Strategy

                23.3.12.5.2. Product Strategy

                23.3.12.5.3. Channel Strategy 

        23.3.13. Aspect Biosystems 

            23.3.13.1. Overview

            23.3.13.2. Product Portfolio

            23.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.13.4. Sales Footprint

            23.3.13.5. Strategy Overview

                23.3.13.5.1. Marketing Strategy

                23.3.13.5.2. Product Strategy

                23.3.13.5.3. Channel Strategy

        23.3.14. CELLINK

            23.3.14.1. Overview

            23.3.14.2. Product Portfolio

            23.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.14.4. Sales Footprint

            23.3.14.5. Strategy Overview

                23.3.14.5.1. Marketing Strategy

                23.3.14.5.2. Product Strategy

                23.3.14.5.3. Channel Strategy

        23.3.15. GeSiM

            23.3.15.1. Overview

            23.3.15.2. Product Portfolio

            23.3.15.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.15.4. Sales Footprint

            23.3.15.5. Strategy Overview

                23.3.15.5.1. Marketing Strategy

                23.3.15.5.2. Product Strategy

                23.3.15.5.3. Channel Strategy

        23.3.16. Bio3D Technologies Pte. Ltd. 

            23.3.16.1. Overview

            23.3.16.2. Product Portfolio

            23.3.16.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.16.4. Sales Footprint

            23.3.16.5. Strategy Overview

                23.3.16.5.1. Marketing Strategy

                23.3.16.5.2. Product Strategy

                23.3.16.5.3. Channel Strategy

        23.3.17. Optomec Inc.

            23.3.17.1. Overview

            23.3.17.2. Product Portfolio

            23.3.17.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.17.4. Sales Footprint

            23.3.17.5. Strategy Overview

                23.3.17.5.1. Marketing Strategy

                23.3.17.5.2. Product Strategy

                23.3.17.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global 3D Bioprinting Market Demand (in Volume 000'Units) Analysis- and Opportunity Assessment 2015–2030, By Technology

Table 02: Global 3D Bioprinting Market Value (US$ Mn) Analysis- and Opportunity Assessment 2015–2030, By Technology

Table 03: Global 3D Bioprinting Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Application

Table 04: Global 3D Bioprinting Market Value (US$ Mn) Analysis- and Opportunity Assessment 2015–2030, By End User

Table 05: Global 3D Bioprinting Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region

Table 06: North America 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 07: North America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 08: North America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application

Table 09: North America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 10: North America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 11: Latin America 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 12: Latin America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 13: Latin America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application

Table 14: Latin America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 15: Latin America 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 16: Europe 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 17: Europe 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 18: Europe 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application

Table 19: Europe 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 20: Europe 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 21: South Asia 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 22: South Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 23: South Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application

Table 24: South Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 25: South Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 26: East Asia 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 27: East Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 28: East Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application

Table 29: East Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 30: East Asia 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 31: Oceania 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 32: Oceania 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 33: Oceania 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application

Table 34: Oceania 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 35: Oceania 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Table 36: Middle East and Africa 3D Bioprinting Market Demand (in Volume 000'Units) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 37: Middle East and Africa 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Technology

Table 38: Middle East and Africa 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Application

Table 39: Middle East and Africa 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By End User

Table 40: Middle East and Africa 3D Bioprinting Market Value (US$ Mn) Analysis 2015-2019 and Forecast 2020–2030, By Country

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global 3D Bioprinting Market Historical Market Volume Analysis, 2015-2019

Figure 2: Global 3D Bioprinting Current and Future Market Volume, 2020-2030 & Y-o-Y Growth Trend Analysis

Figure 03: Global 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019

Figure 04: Global 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030

Figure 05: Global 3D Bioprinting Market Absolute $ Opportunity, 2020-2030

Figure 06: Global 3D Bioprinting Market Share Analysis (%), By Technology, 2020 & 2030

Figure 07: Global 3D Bioprinting Market Y-o-Y Analysis (%), By Technology, 2020-2030

Figure 08: Global 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030 

Figure 09: Global 3D Bioprinting Market Share Analysis (%), By Application, 2020 & 2030

Figure 10: Global 3D Bioprinting Market Y-o-Y Analysis (%), By Application, 2020-2030

Figure 11: Global 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030 

Figure 12: Global 3D Bioprinting Market Share Analysis (%), By End User, 2020 & 2030

Figure 13: Global 3D Bioprinting Market Y-o-Y Analysis (%), By End User, 2020-2030

Figure 14: Global 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030 

Figure 15: Global 3D Bioprinting Market Share Analysis (%), By Region, 2020 & 2030

Figure 16: Global 3D Bioprinting Market Y-o-Y Analysis (%), By Region, 2020-2030

Figure 17: Global 3D Bioprinting Market Attractiveness Analysis by Region, 2020-2030

Figure 18: North America 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019

Figure 19: North America 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030

Figure 20: North America 3D Bioprinting Market Share, By Technology (2020)

Figure 21: North America 3D Bioprinting Market Share, By End User (2020)

Figure 22: North America 3D Bioprinting Market Share, By Application (2020)

Figure 23: North America 3D Bioprinting Market Share, By Country (2020)

Figure 24: North America 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030 

Figure 25: North America 3D Bioprinting Market  Attractiveness Analysis By Application, 2020-2030

Figure 26: North America 3D Bioprinting Market  Attractiveness Analysis By End User, 2020-2030 

Figure 27: North America 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030 

Figure 28: Latin America 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019

Figure 29: Latin America 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030

Figure 30: Latin America 3D Bioprinting Market Share, By Technology (2020)

Figure 31: Latin America 3D Bioprinting Market Share, By End User (2020)

Figure 32: Latin America 3D Bioprinting Market Share, By Application (2020)

Figure 33: Latin America 3D Bioprinting Market Share, By Country (2020)

Figure 34: Latin America 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030 

Figure 35: Latin America 3D Bioprinting Market  Attractiveness Analysis By Application, 2020-2030

Figure 36: Latin America 3D Bioprinting Market  Attractiveness Analysis By End User, 2020-2030 

Figure 37: Latin America 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030 

Figure 38: Europe 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019

Figure 39: Europe 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030

Figure 40: Europe 3D Bioprinting Market Share, By Technology (2020)

Figure 41: Europe 3D Bioprinting Market Share, By End User (2020)

Figure 42: Europe 3D Bioprinting Market Share, By Application (2020)

Figure 43: Europe 3D Bioprinting Market Share, By Country (2020)

Figure 44: Europe 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030 

Figure 45: Europe 3D Bioprinting Market  Attractiveness Analysis By Application, 2020-2030

Figure 46: Europe 3D Bioprinting Market  Attractiveness Analysis By End User, 2020-2030 

Figure 47: Europe 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030 

Figure 48: South Asia 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019

Figure 49: South Asia 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030

Figure 50: South Asia 3D Bioprinting Market Share, By Technology (2020)

Figure 51: South Asia 3D Bioprinting Market Share, By End User (2020)

Figure 52: South Asia 3D Bioprinting Market Share, By Application (2020)

Figure 53: South Asia 3D Bioprinting Market Share, By Country (2020)

Figure 54: South Asia 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030 

Figure 55: South Asia 3D Bioprinting Market  Attractiveness Analysis By Application, 2020-2030

Figure 56: South Asia 3D Bioprinting Market  Attractiveness Analysis By End User, 2020-2030 

Figure 57: South Asia 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030 

Figure 58: East Asia 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019

Figure 59: East Asia 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030

Figure 60: East Asia 3D Bioprinting Market Share, By Technology (2020)

Figure 61: East Asia 3D Bioprinting Market Share, By End User (2020)

Figure 62: East Asia 3D Bioprinting Market Share, By Application (2020)

Figure 63: East Asia 3D Bioprinting Market Share, By Country (2020)

Figure 64: East Asia 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030 

Figure 65: East Asia 3D Bioprinting Market  Attractiveness Analysis By Application, 2020-2030

Figure 66: East Asia 3D Bioprinting Market  Attractiveness Analysis By End User, 2020-2030 

Figure 67: East Asia 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030 

Figure 68: Oceania 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019

Figure 69: Oceania 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030

Figure 70: Oceania 3D Bioprinting Market Share, By Technology (2020)

Figure 71: Oceania 3D Bioprinting Market Share, By End User (2020)

Figure 72: Oceania 3D Bioprinting Market Share, By Application (2020)

Figure 73: Oceania 3D Bioprinting Market Share, By Country (2020)

Figure 74: Oceania 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030 

Figure 75: Oceania 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030

Figure 76: Oceania 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030 

Figure 77: Oceania 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030 

Figure 78: Middle East and Africa 3D Bioprinting Market Value Analysis (US$ Mn), 2015-2019

Figure 79: Middle East and Africa 3D Bioprinting Market Value Forecast (US$ Mn), 2020-2030 & Y-o-Y Growth (%), 2020-2030

Figure 80: Middle East and Africa 3D Bioprinting Market Share, By Technology (2020)

Figure 81: Middle East and Africa 3D Bioprinting Market Share, By End User (2020)

Figure 82: Middle East and Africa 3D Bioprinting Market Share, By Application (2020)

Figure 83: Middle East and Africa 3D Bioprinting Market Share, By Country (2020)

Figure 84: Middle East and Africa 3D Bioprinting Market Attractiveness Analysis By Technology, 2020-2030 

Figure 85: Middle East and Africa 3D Bioprinting Market Attractiveness Analysis By Application, 2020-2030

Figure 86: Middle East and Africa 3D Bioprinting Market Attractiveness Analysis By End User, 2020-2030 

Figure 87: Middle East and Africa 3D Bioprinting Market Attractiveness Analysis By Country, 2020-2030 

Figure 88: U.S Market Value Proportion Analysis, 2020

Figure 89: Global Vs. U.S Growth Comparison

Figure 90: U.S. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 91: U.S. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 92: U.S. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 93: Canada Market Value Proportion Analysis, 2020

Figure 94: Global Vs. Canada Growth Comparison

Figure 95: Canada. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 96: Canada. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 97: Canada. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 98: Mexico Market Value Proportion Analysis, 2020

Figure 99: Global Vs. Mexico Growth Comparison

Figure 101: Mexico. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 102: Mexico. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 103: Mexico. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 104: Brazil Market Value Proportion Analysis, 2020

Figure 105: Global Vs. Brazil Growth Comparison

Figure 106: Brazil. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 107: Brazil. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 107: Brazil. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 108: U.K. Market Value Proportion Analysis, 2020

Figure 109: Global Vs. U.K. Growth Comparison

Figure 110: U.K. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 111: U.K. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 112: U.K. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 113: Germany Market Value Proportion Analysis, 2020

Figure 114: Global Vs. Germany Growth Comparison

Figure 115: Germany. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 116: Germany. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 117: Germany. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 118: France Market Value Proportion Analysis, 2020

Figure 119: Global Vs. France Growth Comparison

Figure 120: France. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 121: France. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 122: France. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 123: Italy Market Value Proportion Analysis, 2020

Figure 124: Global Vs. Italy Growth Comparison

Figure 125: Italy. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 126: Italy. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 127: Italy. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 128: Spain Market Value Proportion Analysis, 2020

Figure 129: Global Vs. Spain Growth Comparison

Figure 130: Spain. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 131: Spain. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 132: Spain. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 133: Russia Market Value Proportion Analysis, 2020

Figure 134: Global Vs. Russia Growth Comparison

Figure 135: Russia. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 136: Russia. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 137: Russia. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 138: China Market Value Proportion Analysis, 2020

Figure 139: Global Vs. China Growth Comparison

Figure 140: China. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 141: China. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 142: China. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 143: Japan Market Value Proportion Analysis, 2020

Figure 144: Global Vs. Japan Growth Comparison

Figure 145: Japan. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 146: Japan. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 147: Japan. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 148: South Korea Market Value Proportion Analysis, 2020

Figure 149: Global Vs. South Korea Growth Comparison

Figure 150: South Korea. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 151: South Korea. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 152: South Korea. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 153: India Market Value Proportion Analysis, 2020

Figure 154: Global Vs. India Growth Comparison

Figure 155: India. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 156: India. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 157: India. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 158: Indonesia Market Value Proportion Analysis, 2020

Figure 159: Global Vs. Indonesia Growth Comparison

Figure 160: Indonesia. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 161: Indonesia. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 162: Indonesia. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 163: Australia Market Value Proportion Analysis, 2020

Figure 164: Global Vs. Australia Growth Comparison

Figure 165: Australia. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 166: Australia. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 167: Australia. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 168: New Zealand Market Value Proportion Analysis, 2020

Figure 169: Global Vs. New Zealand Growth Comparison

Figure 170: New Zealand. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 171: New Zealand. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 172: New Zealand. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 173: GCC Countries Market Value Proportion Analysis, 2020

Figure 174: Global Vs. GCC Countries Growth Comparison

Figure 175: GCC Countries. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 176: GCC Countries. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 177: GCC Countries. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 178: South Africa Market Value Proportion Analysis, 2020

Figure 179: Global Vs. South Africa Growth Comparison

Figure 180: South Africa. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 181: South Africa. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 182: South Africa. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Figure 183: Turkey Market Value Proportion Analysis, 2020

Figure 184: Global Vs. Turkey Growth Comparison

Figure 185: Turkey. 3D Bioprinting Market Share Analysis (%) By Technology, 2020 & 2030

Figure 186: Turkey. 3D Bioprinting Market Share Analysis (%) By Application, 2020 & 2030

Figure 187: Turkey. 3D Bioprinting Market Share Analysis (%) By End User, 2020 & 2030

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

3D Bioprinting Market